Dhruvalben Vishal Shah

Insider activity · 24 months2 buys0 salesCumulative net flow

Nov 24 · 0 buys · 0 salesDec 24 · 0 buys · 0 salesJan 25 · 0 buys · 0 salesFeb 25 · 0 buys · 0 salesMar 25 · 0 buys · 0 salesApr 25 · 0 buys · 0 salesMay 25 · 0 buys · 0 salesJun 25 · 0 buys · 0 salesJul 25 · 0 buys · 0 salesAug 25 · 0 buys · 0 salesSept 25 · 0 buys · 0 salesOct 25 · 0 buys · 0 salesNov 25 · 0 buys · 0 salesDec 25 · 1 buy · 0 salesJan 26 · 0 buys · 0 salesFeb 26 · 1 buy · 0 salesMar 26 · 0 buys · 0 salesApr 26 · 0 buys · 0 salesMay 26 · 0 buys · 0 salesJun 26 · 0 buys · 0 salesJul 26 · 0 buys · 0 salesAug 26 · 0 buys · 0 salesSept 26 · 0 buys · 0 salesOct 26 · 0 buys · 0 sales

Total declarations

Company

▲ Purchases (2 ops.)

€3,621

▼ Sales (0 ops.)

—

Latest filing published 26 Feb 2026 for Senores Pharmaceuticals Limited, €2,535. Read the official filing

Filing timeline

BuySale

Dhruvalben Vishal Shah

Dhruvalben Vishal Shah: trading record in brief

Dhruvalben Vishal Shah discloses dealings in Senores Pharmaceuticals Limited to SEBI (PIT + SAST). We count 2 filings; the first trade dates from 11 December 2025 and the latest from 24 February 2026.

The open-market record is one-sided, with 2 purchases worth €3,621 and not one sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. So far in 2026, the count stands at 1 purchase and no sales.

The record was last updated on 26 February 2026 with an open-market purchase (€2,535) in Senores Pharmaceuticals Limited. This summary is built from SEBI (PIT + SAST) disclosures alone and does not predict where the share price will go.